JP2015508097A5 - - Google Patents

Download PDF

Info

Publication number
JP2015508097A5
JP2015508097A5 JP2014558258A JP2014558258A JP2015508097A5 JP 2015508097 A5 JP2015508097 A5 JP 2015508097A5 JP 2014558258 A JP2014558258 A JP 2014558258A JP 2014558258 A JP2014558258 A JP 2014558258A JP 2015508097 A5 JP2015508097 A5 JP 2015508097A5
Authority
JP
Japan
Prior art keywords
methyl
ethyl
chroman
amino
naphthalen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014558258A
Other languages
English (en)
Japanese (ja)
Other versions
JP6114316B2 (ja
JP2015508097A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2013/051445 external-priority patent/WO2013124828A1/en
Publication of JP2015508097A publication Critical patent/JP2015508097A/ja
Publication of JP2015508097A5 publication Critical patent/JP2015508097A5/ja
Application granted granted Critical
Publication of JP6114316B2 publication Critical patent/JP6114316B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014558258A 2012-02-24 2013-02-22 カルシウム感知受容体調節剤としての置換クロマン化合物 Active JP6114316B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
IN178/KOL/2012 2012-02-24
IN178KO2012 2012-02-24
IN1030KO2012 2012-09-07
IN1030/KOL/2012 2012-09-07
PCT/IB2013/051445 WO2013124828A1 (en) 2012-02-24 2013-02-22 Substituted chroman compounds as calcium sensing receptor modulators

Publications (3)

Publication Number Publication Date
JP2015508097A JP2015508097A (ja) 2015-03-16
JP2015508097A5 true JP2015508097A5 (enExample) 2016-01-28
JP6114316B2 JP6114316B2 (ja) 2017-04-12

Family

ID=54261188

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014558258A Active JP6114316B2 (ja) 2012-02-24 2013-02-22 カルシウム感知受容体調節剤としての置換クロマン化合物

Country Status (44)

Country Link
US (3) US9163001B2 (enExample)
EP (1) EP2817299B1 (enExample)
JP (1) JP6114316B2 (enExample)
KR (1) KR102041154B1 (enExample)
CN (1) CN104350047B (enExample)
AP (1) AP2014007919A0 (enExample)
AR (1) AR090135A1 (enExample)
AU (1) AU2013223715B2 (enExample)
BR (1) BR112014021133B1 (enExample)
CA (1) CA2864332C (enExample)
CL (1) CL2014002218A1 (enExample)
CO (1) CO7160018A2 (enExample)
CR (1) CR20140424A (enExample)
CU (1) CU24325B1 (enExample)
CY (1) CY1122017T1 (enExample)
DK (1) DK2817299T3 (enExample)
DO (1) DOP2014000193A (enExample)
EA (1) EA026940B9 (enExample)
ES (1) ES2743492T3 (enExample)
GE (2) GEAP201813579A (enExample)
GT (1) GT201400179A (enExample)
HR (1) HRP20191606T1 (enExample)
HU (1) HUE046172T2 (enExample)
IL (1) IL234252A (enExample)
IN (1) IN2014MN01672A (enExample)
LT (1) LT2817299T (enExample)
MA (1) MA35937B1 (enExample)
MX (1) MX355670B (enExample)
MY (1) MY171374A (enExample)
NI (1) NI201400094A (enExample)
NZ (1) NZ628627A (enExample)
PE (1) PE20142281A1 (enExample)
PH (1) PH12014501891B1 (enExample)
PL (1) PL2817299T3 (enExample)
PT (1) PT2817299T (enExample)
RS (1) RS59172B1 (enExample)
SG (1) SG11201405117SA (enExample)
SI (1) SI2817299T1 (enExample)
SM (1) SMT201900506T1 (enExample)
TN (1) TN2014000352A1 (enExample)
TW (1) TWI617549B (enExample)
UA (1) UA112679C2 (enExample)
WO (1) WO2013124828A1 (enExample)
ZA (1) ZA201405990B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102041154B1 (ko) * 2012-02-24 2019-11-07 루핀 리미티드 칼슘 감지 수용체 조절자로서의 치환 크로만 화합물
HK1211916A1 (en) * 2012-08-27 2016-06-03 Lupin Atlantis Holdings Sa Arylalkylamine compounds as calcium sensing receptor modulators
TW201602062A (zh) 2013-08-12 2016-01-16 魯賓有限公司 取代聯苯基化合物作為鈣敏感受體調節劑
US9493396B2 (en) 2013-08-28 2016-11-15 Lupin Atlantis Holdings Sa Substituted naphthalene compounds as calcium sensing receptor modulators
WO2015162538A1 (en) 2014-04-21 2015-10-29 Lupin Limited Heterocyclic compounds as calcium sensing receptor modulators for the treatment of hyperparathyroidism, chronic renal failure and chronic kidney disease
WO2017037616A1 (en) 2015-08-31 2017-03-09 Lupin Limited Arylalkylamine compounds as calcium sensing receptor modulators
PH12022551057A1 (en) * 2019-11-19 2023-09-18 Lupin Ltd Process for preparing chroman compounds
AU2020415502A1 (en) 2019-12-27 2022-07-14 Lupin Limited Pharmaceutical composition of CaSR modulators and methods and uses thereof
SI4090654T1 (sl) * 2020-01-17 2025-11-28 Lupin Ltd. Metode, postopki in intermediati za pripravo kromanskih spojin
WO2025255092A1 (en) * 2024-06-03 2025-12-11 Artax Biopharma Inc. Combination of a chromene derivative tcr inhibitor and a tyk2 inhibitor

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3063585D1 (en) * 1979-05-19 1983-07-07 Beecham Group Plc Chroman derivatives, processes for their preparation and pharmaceutical compositions containing them
US5387587A (en) * 1986-12-23 1995-02-07 Merck Patent Gesellschaft Mit Beschrankter Haftung Chroman derivatives
US6133277A (en) 1997-12-05 2000-10-17 Janssen Pharmaceutica N.V. (Benzodioxan, benzofuran or benzopyran) derivatives having fundic relaxation properties
FR2809396B1 (fr) 2000-05-24 2005-10-14 Centre Nat Rech Scient Nouvelles molecules possedant une activite calcimimetique et leur mode de preparation
FR2812875B1 (fr) 2000-08-08 2003-12-12 Centre Nat Rech Scient Nouvelles diamines possedant une activite modulatrice des casr et leur mode de preparation
US7105537B2 (en) 2003-01-28 2006-09-12 Bristol-Myers Squibb Company 2-substituted cyclic amines as calcium sensing receptor modulators
CA2527203C (en) 2003-05-28 2010-08-17 Japan Tobacco Inc. Casr antagonist
EP1882684B1 (en) 2005-05-19 2014-12-10 Astellas Pharma Inc. Pyrrolidine derivative or salt thereof
TW200815388A (en) 2006-04-18 2008-04-01 Wyeth Corp Chromane and chromene derivatives and uses thereof
CA2663436A1 (en) 2006-10-04 2008-04-10 Pfizer Products Inc. Pyrido[4,3-d]pyrimidin-4(3h)-one derivatives as calcium receptor antagonists
MX2009003981A (es) * 2006-10-26 2009-04-27 Amgen Inc Agentes moduladores del receptor de calcio.
WO2008059854A1 (en) 2006-11-16 2008-05-22 Astellas Pharma Inc. Piperidine derivatives or salts thereof
US8334317B2 (en) * 2007-10-15 2012-12-18 Amgen Inc. Calcium receptor modulating agents
CA2706076A1 (en) 2007-11-23 2009-05-28 Leo Pharma A/S Novel cyclic hydrocarbon compounds for the treatment of diseases
WO2010038895A1 (ja) 2008-10-03 2010-04-08 味の素株式会社 CaSRアゴニスト
WO2010042642A1 (en) 2008-10-08 2010-04-15 Amgen Inc. Calcium receptor modulating agents
WO2010136037A1 (en) 2009-05-27 2010-12-02 Leo Pharma A/S Novel calcium sensing receptor modulating compounds and pharmaceutical use thereof
WO2010150837A1 (ja) 2009-06-25 2010-12-29 第一三共株式会社 インドリン誘導体
WO2012069421A1 (en) 2010-11-26 2012-05-31 Leo Pharma A/S Calcium-sensing receptor-active compounds
WO2012069402A1 (en) 2010-11-26 2012-05-31 Leo Pharma A/S Substituted cyclopentyl - azines as casr- active compounds
CN103270018A (zh) 2010-11-26 2013-08-28 利奥制药有限公司 钙敏感受体激活化合物
AU2012226375B2 (en) 2011-03-10 2017-04-13 Lupin Atlantis Holdings Sa Substituted morpholines as modulators for the calcium sensing receptor
SG193331A1 (en) 2011-03-18 2013-10-30 Lupin Ltd Benzo [b] [1, 4] oxazin derivatives as calcium sensing receptor modulators
KR102041154B1 (ko) * 2012-02-24 2019-11-07 루핀 리미티드 칼슘 감지 수용체 조절자로서의 치환 크로만 화합물

Similar Documents

Publication Publication Date Title
RU2012125372A (ru) Производные пиразола в качестве ингибиторов 11-бета-hsd1
JP2012506896A5 (enExample)
JP2026048714A (ja) 疾患の予防または治療に有用な官能化長鎖炭化水素モノカルボン酸及びジカルボン酸
JP2010529147A5 (enExample)
JP2017526727A5 (enExample)
EA201100698A1 (ru) Производные тиенотриазолодиазепина, активные в отношении апо а1
JP2010535704A5 (enExample)
JP2004529145A5 (enExample)
RU2007116317A (ru) Гексафторизопропанол-замещенные производные простых эфиров
JP2012507535A5 (enExample)
JP2006520755A5 (enExample)
JP2007502265A5 (enExample)
JP2020527175A5 (enExample)
RU2008143232A (ru) Новый класс ингибиторов гистондеацетилаз
JP2017505293A5 (enExample)
RU2481345C2 (ru) Замещенные (оксазолидинон-5-ил-метил)-2-тиофен-карбоксамиды и их применение в области свертывания крови
JP2010516701A5 (enExample)
JP2016504992A5 (enExample)
HRP20191606T1 (hr) Supstituirani spojevi kromana kao modulatori receptora osjetljivog na kalcij
JP6227635B2 (ja) 重水素化ベンゾピラン類化合物及びその応用
JP2004525184A5 (enExample)
JP2010504321A5 (enExample)
JP2004509121A5 (enExample)
CN1202104C (zh) 2-苯基吡喃-4-酮衍生物
RU2466127C2 (ru) Бензилпиперидиновое производное